# EDGAR Filing Document

**Accession Number:** 0001889450
**File Stem:** 0001493152-25-023666
**Filing Date:** 2025-11
**Character Count:** 7034
**Document Hash:** d9a21157749063a4e23f997f42392ad5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-023666.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001493152-25-023666

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**EFFECTIVENESS DATE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FutureTech II Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001889450
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 872551539
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41289
- **FILM NUMBER:** 251488370

**BUSINESS ADDRESS:**
- **STREET 1:** 128 GAIL DRIVE
- **CITY:** NEW ROCHELLE
- **STATE:** NY
- **ZIP:** 10805
- **BUSINESS PHONE:** 9143164805

**MAIL ADDRESS:**
- **STREET 1:** 128 GAIL DRIVE
- **CITY:** NEW ROCHELLE
- **STATE:** NY
- **ZIP:** 10805

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Future Tech II Acquisition Corp.
- **DATE OF NAME CHANGE:** 20211020

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 12b-25**

---

| | |
|:---|:---|
| **NOTIFICATION OF LATE FILING** | SEC FILE<br> NUMBER |
| **NOTIFICATION OF LATE FILING** | 001-41497 |
|  | CUSIP<br> NUMBER |
|  | 27877D104 |

---

*(Check one):* ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

---

| |
|:---|
| For Period Ended: <u>September 30, 2025</u> |
| ☐ Transition Report on Form 10-K |
| ☐ Transition Report on Form 20-F |
| ☐ Transition Report on Form 11-K |
| ☐ Transition Report on Form 10-Q |
| ☐ Transition Report on Form N-SAR |
| For the Transition Period Ended:________________________ |

---

*Read attached instruction sheet before preparing form. Please Print or Type.*<br> Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.<br>

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: <br> 

PART I - REGISTRANT INFORMATION

---

| |
|:---|
| FutureTech II Acquisition Corp. |
| Full Name of Registrant |
| Former Name if Applicable |
| 128 Gail Drive |
| Address of Principal Executive Office *(Street and Number)* |
| New Rochelle, NY 10805 |
| City, State and Zip Code |

---

**PART II**

**RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

---

| | | |
|:---|:---|:---|
| ☒ | (a) | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| ☒ | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or From N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| ☒ | (c) | The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

---

**PART III**

**NARRATIVE**

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

FutureTech II Acquisition Corp. (the "Company") has determined that it is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025 (the "Form 10-Q") within the prescribed time period without unreasonable effort or expense due to the reasons described below. The management of the Company has been working diligently to complete all of the required information for the Form 10-Q, and a substantial part of such information has been completed as of this date. However, the Company requires additional time to prepare, review and finalize its financial statements to be included in the Form 10-Q.

**PART IV**

**OTHER INFORMATION**

---

| | | | |
|:---|:---|:---|:---|
| (1) | Name and telephone number of person to contact in regard to this notification | Name and telephone number of person to contact in regard to this notification | Name and telephone number of person to contact in regard to this notification |
|  | Ray Chen | (914) | 316-4805 |
|  | (Name) | (Area Code) | (Telephone Number) |

---

(2) Have
 all other periodic reports required under Section 13 or 15(d) of the Securities Exchange
 Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months
 (or for such shorter) period that the registrant was required to file such reports) been
 filed? If answer is no, identify report(s). ☒
 Yes ☐ No

(3) Is
 it anticipated that any significant change in results of operations from the corresponding period
 for the last fiscal year will be reflected by the earnings statements to be included in the subject
 report or portion thereof? ☒ Yes ☐ No If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.

Based on preliminary information, primarily as a result of a material decrease in investment income, the Company expects to report a net loss for the three months ended September 30, 2025, which will be greater than the loss for the three months ended September 30, 2024 and a net loss for the nine months ended September 30, 2025 as compared to net income for the nine months ended September 30, 2024.

<u>FutureTech II Acquisition Corp.</u> <br> (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: November 14, 2025 | By: | */s/ Ray Chen* |
|  | Name: | Ray Chen |
|  | Title: | CEO |

---

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

---

| | |
|:---|:---|
| | **ATTENTION** |
|  | **ATTENTION** |
| **Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).** | **Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).** |

---